- Chief Compliance Officer and VP of Legal Affairs, Arrow Electronics
In the face of tax reform, companies with deferred tax assets on balance sheets could be looking at hits to earnings. But, asks Tammy Whitehouse, is that a risk to disclose to investors?
THIS IS MEMBERS-ONLY CONTENT. To continue reading, choose one of the options below.
News and analysis for the well-informed compliance or audit exec. Select an option and click continue.
Annual Membership $499 Value offer
Full price one year membership with auto-renewal.
Membership $599
One-year only, no auto-renewal.
As the tax reform debate sputters, companies have some big decisions to make about where to make and hedge their bets when it comes to tax planning.
Taking a back seat to healthcare reform, tax reform is still on the agenda, with experts predicting Congressional action in late 2017 or early 2018.
Becton Dickinson medical device company will pay $175 million for “repeatedly” misleading investors about its Alaris infusion pump, a product the company knew was flawed and was sold without the required patient-safety approvals, the Securities and Exchange Commission said.
